CDEK
← All organizations

Alkermes

For profitContributed to NMEWebsite ↗

Also known as: ALKERMES | ALKERMES GAINESVILLE | Alkermes, Inc. | ALKERMES INC | Alkermes Medical Director

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Nov 2, 1999

First marketed drug

Dec 10, 1997

First NDA

May 28, 2021

Last known activity

Apr 30, 2025

Timeline

1980s

  1. Jan 1, 1987

    Alkermes— Founded

1990s

  1. Jan 1, 1996

    Medisorb Technologies— Acquired

  2. Sep 22, 1998

    isosorbide— Marketing Organization

2010s

  1. Nov 28, 2019

    Rodin Therapeutics— Acquired

2020s

  1. May 28, 2021

    samidorphan— NDA Organization

  2. May 28, 2021

    samidorphan— NDA Secondary Org

  3. Nov 19, 2025

    Avadel Pharmaceuticals— Acquired

Drugs by trial phase (44 distinct, 121 trials)

Phase 4 (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (6)

Subsidiaries (3 direct, 4 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Waltham, MA, US Jan 1, 1987
First NDA
May 28, 2021
Last known activity
Apr 30, 2025